Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivacaftor Effects on Wild Type CFTR in Sweat Glands
NCT02310789Completed
- Start
- Jul 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ivacaftor in cystic fibrosis (CF). Primary endpoint: Change in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Dependent Sweat Rate at 79 days. Started Jul 2015; status: completed.
02
Drugs
ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02310789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02310789.